Vascular Endothelial Growth Factor Enhances Cardiac Allograft Arteriosclerosis
Authors:
- Karl B. LemströmKLKarl B. Lemström
- Rainer KrebsRKRainer Krebs
- Antti I. NykänenANAntti I. Nykänen
- Jussi M. TikkanenJTJussi M. Tikkanen
- Roope K. SihvolaRSRoope K. Sihvola
- Eva M. AaltolaEAEva M. Aaltola
- Pekka J. HäyryPHPekka J. Häyry
- Jeanette WoodJWJeanette Wood
- Kari AlitaloKAKari Alitalo
- Seppo Ylä-HerttualaSeppo Ylä-Herttuala
- Petri K. KoskinenPKPetri K. Koskinen
- 28 May 2002
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 105 (21) , 2524-2530
Abstract
Background — Cardiac allograft arteriosclerosis is a complex process of alloimmune response, chronic inflammation, and smooth muscle cell proliferation that includes cross talk between cytokines and growth factors. Methods and Results — Our results in rat cardiac allografts established alloimmune response as an alternative stimulus capable of inducing vascular endothelial growth factor (VEGF) mRNA and protein expression in cardiomyocytes and graft-infiltrating mononuclear inflammatory cells, which suggests that these cells may function as a source of VEGF to the cells of coronary arteries. Linear regression analysis of these allografts with different stages of arteriosclerotic lesions revealed a strong correlation between intragraft VEGF protein expression and the development of intimal thickening, whereas blockade of signaling downstream of VEGF receptor significantly reduced arteriosclerotic lesions. In addition, in cholesterol-fed rabbits, intracoronary perfusion of cardiac allografts with a clinical-grade adenoviral vector that encoded mouse VEGF 164 enhanced the formation of arteriosclerotic lesions, possibly secondary to increased intragraft influx of macrophages and neovascularization in the intimal lesions. Conclusions — Our findings suggest a positive regulatory role between VEGF and coronary arteriosclerotic lesion formation in the allograft cytokine microenvironment.Keywords
This publication has 18 references indexed in Scilit:
- Vascular Endothelial Growth Factor Expression of Intercellular Adhesion Molecule 1 (ICAM-1), Vascular Cell Adhesion Molecule 1 (VCAM-1), and E-selectin through Nuclear Factor-κB Activation in Endothelial CellsJournal of Biological Chemistry, 2001
- Vascular Endothelial Growth Factor-Induced Migration of Vascular Smooth Muscle Cells in VitroMicrovascular Research, 1999
- PDGF, TGF-β, and Heterotypic Cell–Cell Interactions Mediate Endothelial Cell–induced Recruitment of 10T1/2 Cells and Their Differentiation to a Smooth Muscle FateJournal of Cell Biology, 1998
- Passivation of Metallic Stents After Arterial Gene Transfer of phVEGF165Inhibits Thrombus Formation and Intimal ThickeningJACC, 1997
- Hypoxia and platelet‐derived growth factor‐BB synergistically upregulate the expression of vascular endothelial growth factor in vascular smooth muscle cellsFEBS Letters, 1995
- Induction of Vascular Endothelial Growth Factor Gene Expression by Interleukin-1 β in Rat Aortic Smooth Muscle CellsJournal of Biological Chemistry, 1995
- Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model.Journal of Clinical Investigation, 1994
- Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration.Journal of Experimental Medicine, 1990
- Expression of the proto-oncogene int-1 is restricted to specific neural cells in the developing mouse embryoCell, 1987
- Hypothesis: Vasa Vasorum and Neovascularization of Human Coronary ArteriesNew England Journal of Medicine, 1984